Skip to content

Clinical trials

Enrolling by invitation Carcinoma, Hepatocellular trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Enrolling by invitation Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20141
20151
20202
20212
20232
20245
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fujian Provincial Hospital2
Abbisko Therapeutics Co, Ltd1
Ain Shams University1
Baylor Research Institute1
Beijing Tsinghua Chang Gung Hospital1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
Exelixis1
GrandPharma (China) Co., Ltd.1
Icahn School of Medicine at Mount Sinai1
Maria dels Angels Cebria i Iranzo, PT, PhD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular20
Liver Cirrhosis3
Liver Neoplasms3
Carcinoma, Renal Cell2
Fibrosis2
Neoplasms2
Colorectal Neoplasms1
Hepatitis B, Chronic1
Hepatitis C, Chronic1
Hypoxia1

Trials

Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.